Crane Introduces Next-Generation Diaphragm Pump - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Crane Introduces Next-Generation Diaphragm Pump

Equipment and Processing Report

Crane’s DEPA DH next-generation double air-operated diaphragm pump has a newly designed pump chamber, center design, manifold, and free-flow-path technology. The pump features flexible multi-port connections; a customized manifold design improves ball-valve guidance, increases functionality, and provides up to 25 different installation options. Cast feet integrated in the center block housing enable maintenance in place that, compared to the previous model, can reduce downtime by up to 25% and decrease the number of required parts by 30%. The block-mounted pump and air chambers provide a safe and well-defined diaphragm clamping mechanism. The diaphragm is fixed to its specifications to provide consistent lifetime wear and tear and eliminate overstretching of the pump. A new flow design with free-flow-path technology can accommodate particle sizes up to 25 mm, increase the scope of applications, and reduce the total cost of ownership through enhanced efficiency.

Source: Crane

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here